Cinética y capacidad neutralizante de los anticuerpos homólogos y ...

Referencias Bibliográficas
39. Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and
flavivirus group determinants identified with monoclonal antibodies by indirect
immunofluorescence. Am J Trop Med Hyg 1982;31(4):830-6.
40. Trent DW. Antigenic characterization of flavivirus structural proteins separated by
isoelectric focusing. J Virol 1977;22(3):608-18.
41. Halstead SB, Heinz FX, Barrett AD, Roehrig JT. Dengue virus: molecular basis of
cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 2005;23(7):849-56.
42. Randolph VB, Stollar V. Low pH-induced cell fusion in flavivirus-infected Aedes
albopictus cell cultures. J Gen Virol 1990;71(Pt 8):1845-50.
43. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990;3(4):376-96.
44. Mandl CW, Heinz FX, Stockl E, Kunz C. Genome sequence of tick-borne
encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins
with other flaviviruses. Virology 1989;173(1):291-301.
45. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization,
expression, and replication. Ann Rev Microbiol 1990;44:649-88.
46. Konishi E, Mason PW. Proper maturation of the Japanese encephalitis virus
envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol
1993;67(3):1672-5.
47. Wang S, He R, Anderson R. PrM- and cell-binding domains of the dengue virus E
protein. J Virol 1999;73(3):2547-51.
48. Parrish CR, Woo WS, Wright PJ. Expression of the NS1 gene of dengue virus type
2 using vaccinia virus. Dimerisation of the NS1 glycoprotein. Arch Virol 1991;117(3-
4):279-86.
49. Fan W, Mason PW. Membrane association and secretion of the Japanese
encephalitis virus NS1 protein from cells expressing NS1 complementary DNA. Virology
1990;177(2):470-476.
50. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High
circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness
correlate with the development of dengue hemorrhagic fever. J Infect Dis
2002;186(8):1165-8.
51. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, et al. Dengue NS1specific
antibody responses: isotype distribution and serotyping in patients with Dengue
fever and Dengue hemorrhagic fever. J Med Virol 2000;62(2):224-32.
52. Chambers TJ, McCourt DW, Rice CM. Yellow fever virus proteins NS2A, NS2B,
and NS4B: identification and partial N-terminal amino acid sequence analysis. Virology
1989;169(1):100-9.
53. Lindenbach BD, Rice CM. Flaviviridae: The Viruses and Their Replication. In:
Knippe DM, Howley PM, editors. Fields Virology. London-New York-Tokyo: Lippincott
Williams & Wilkins; 2001. p. 991-1042.
54. Tan BH, Fu J, Sugrue RJ, Yap EH, Chan YC, Tan YH. Recombinant dengue type 1
virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase
activity. Virology 1996;216(2):317-25.
55. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, et al.
Human skin Langerhans cells are targets of dengue virus infection. Nat Med
2000;6(7):816-20.
123